FDG PET evaluates immunotherapy for non-small cell lung cancer

Posted by on June 13, 2016 8:50 pm
Categories: health

Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers now report a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient’s own immune system.

Leave a Reply

Your email address will not be published. Required fields are marked *